RocketTickers

Fulcrum Therapeutics Announces Positive Interim Results from Pha

Long
NASDAQ:FULC   Fulcrum Therapeutics, Inc.
FULC: Fulcrum Therapeutics, Inc.
2021-08-10 07:00:00
Fulcrum Therapeutics Announces Positive Interim Results from Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.